JOHNSON & JOHNSON sold CVRX
February 16, 2024 · Form 4 insider transaction
JOHNSON & JOHNSON sold 607,225 shares of CVRx, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 19 days after the transaction.
Footnotes
The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial.; The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.; The Warrant was transferred to JJDC from Biosense Webster, Inc., also a wholly-owned subsidiary of Johnson & Johnson, on February 14, 2024.